Raymond James & Associates Spdr Ser Tr Spdr S&P Biotech E Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
A detailed history of Raymond James & Associates transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Raymond James & Associates holds 383,355 shares of XBI stock, worth $32.5 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
383,355
Previous 355,844
7.73%
Holding current value
$32.5 Million
Previous $33 Million
14.81%
% of portfolio
0.02%
Previous 0.02%
Shares
30 transactions
Others Institutions Holding XBI
# of Institutions
839Shares Held
108MCall Options Held
17.7MPut Options Held
28.5M-
Goldman Sachs Group Inc New York, NY13.1MShares$1.11 Billion0.18% of portfolio
-
Morgan Stanley New York, NY10.9MShares$924 Million0.07% of portfolio
-
Citigroup Inc10.5MShares$887 Million0.45% of portfolio
-
Jpmorgan Chase & CO New York, NY10.4MShares$878 Million0.07% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A68.49MShares$719 Million1.54% of portfolio